Literature DB >> 3616675

Case report 427: Cerebrotendinous xanthomatosis.

M Burnstein, K A Buckwalter, W Martel, K D McClatchey, D Quint.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3616675     DOI： 10.1007/bf00361481

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  11 in total

1.  Xanthoma of the tendo Achilles.

Authors:  G BLOMQVIST
Journal:  Acta radiol       Date:  1962-01       Impact factor: 1.990

2.  Hypercholesteremic xanthomata of the tendons.

Authors:  P D GILBERT; T M KAIN; H C MARCH
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1957-01

3.  A case of type 3 hyperlipoproteinemia with xanthomata.

Authors:  L Weintrob
Journal:  Br J Radiol       Date:  1971-03       Impact factor: 3.039

4.  Familial pseudohypertrophy of tendo-achillis with multisystem disease.

Authors:  J D Hughes; T W Meriwether
Journal:  South Med J       Date:  1971-03       Impact factor: 0.954

5.  Magnetic resonance imaging in cerebrotendinous xanthomatosis.

Authors:  P D Swanson; L D Cromwell
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

6.  Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  T A Pedley; R G Emerson; C L Warner; L P Rowland; G Salen
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

7.  Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.

Authors:  B J Koopman; B G Wolthers; J C van der Molen; R J Waterreus
Journal:  Clin Chim Acta       Date:  1985-10-31       Impact factor: 3.786

8.  A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.

Authors:  S Skrede; I Bjørkhem
Journal:  Scand J Clin Lab Invest Suppl       Date:  1985

9.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

10.  Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.

Authors:  G Salen; S Shefer; G S Tint; G Nicolau; B Dayal; A K Batta
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808
View more
  6 in total

1.  Computed tomography of tendinous xanthomata in cerebrotendinous xanthomatosis.

Authors:  Y Hertzanu; J Berginer; V M Berginer
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

2.  Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Authors:  Y Hokezu; M Kuriyama; R Kubota; M Nakagawa; J Fujiyama; M Osame
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Magnetic resonance imaging of tendon and ligament abnormalities: Part II. Pelvis and lower extremities.

Authors:  J Tehranzadeh; R Kerr; J Amster
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

4.  Case report 754: Xanthoma of the Achilles tendon.

Authors:  S Kenan; I F Abdelwahab; M J Klein; A Aaron; M M Lewis
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 5.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

Review 6.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.